European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study)

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2030

Conditions
Renal Cell Carcinoma
Interventions
OTHER

active surveillance

Follow-up visits will be scheduled 3 (optional) and 6 months after diagnosis, every 6 months up to 3 years and yearly thereafter.

GENETIC

molecular investigation

Transcriptomic analysis of tissues

Trial Locations (1)

28100

RECRUITING

Ospedale Maggiore della Carità, Novara

All Listed Sponsors
collaborator

Università degli Studi del Piemonte Orientale Amedeo Avogadro

OTHER

lead

Azienda Ospedaliero Universitaria Maggiore della Carita

OTHER